1. Home
  2. ATER vs BMRA Comparison

ATER vs BMRA Comparison

Compare ATER & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aterian Inc.

ATER

Aterian Inc.

HOLD

Current Price

$0.56

Market Cap

7.0M

ML Signal

HOLD

Logo Biomerica Inc.

BMRA

Biomerica Inc.

HOLD

Current Price

$2.07

Market Cap

7.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATER
BMRA
Founded
2014
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0M
7.7M
IPO Year
2019
1995

Fundamental Metrics

Financial Performance
Metric
ATER
BMRA
Price
$0.56
$2.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
62.9K
8.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
55.77
N/A
EPS
N/A
N/A
Revenue
$99,045,000.00
$5,311,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.40
52 Week High
$3.50
$4.60

Technical Indicators

Market Signals
Indicator
ATER
BMRA
Relative Strength Index (RSI) 36.62 36.52
Support Level $0.52 N/A
Resistance Level $0.92 $2.40
Average True Range (ATR) 0.06 0.11
MACD -0.00 -0.01
Stochastic Oscillator 21.38 21.07

Price Performance

Historical Comparison
ATER
BMRA

About ATER Aterian Inc.

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Share on Social Networks: